The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)

Published:2020-03-29 Issue:5 Volume:18 Page:415-422
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Soriano Alex¹^ORCID,Rossolini Gian Maria²³^ORCID,Pea Federico⁴⁵^ORCID

Affiliation:

1. Department of Infectious Diseases, University of Barcelona, IDIBAPS, Barcelona, Spain

2. Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

3. Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy

4. Department of Medicine, University of Udine, Udine, Italy

5. Institute of Clinical Pharmacology, Santa Maria Della Misericordia University Hospital of Udine, Udine, Italy

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2020.1746643

Reference61 articles.

1. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections

2. Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)

3. Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs

4. Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update

5. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998–2004)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview;Global and Regional Health Technology Assessment;2024-07-29

2. Evaluation of two commercial broth microdilution systems for dalbavancin susceptibility testing of methicillin-resistant Staphylococcus aureus and other resistant Gram-positive cocci;Clinical Microbiology and Infection;2024-07

3. Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections;Antimicrobial Agents and Chemotherapy;2024-04-03

4. Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study;Journal of Global Antimicrobial Resistance;2024-03

5. Real-World Use of Dalbavancin for Treatment of Soft Tissue and Bone Infection in Children: Safe, Effective and Hospital-Time Sparing;Children;2024-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3